
New Covid-19-test: portable, fast, accurate
Researchers have developped a new coronavirus test, that can get accurate results from a saliva sample in less than 30 minutes.
Researchers have developped a new coronavirus test, that can get accurate results from a saliva sample in less than 30 minutes.
As COVID-19 quickly spread worldwide at the beginning of the year, an urgent need has risen worldwide for specialized health and medical products such as the nasal swabs to collect viral samples or PPE.
A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases.
Engineers have designed a novel sensor that can detect SARS-CoV-2 without any antibodies, giving a result within minutes.
Scientists have developed an algorithm for rapid, computerized diagnosis of COVID-19, overcoming the limitations of reverse transcription polymerase chain reaction.
The number of individuals with COVID-19 in the community was a significant factor associated with stress in health care workers over time.
Engineers have designed a device that can detect SARS-CoV-2 from a saliva sample in about an hour. They showed that the diagnostic is just as accurate as the PCR tests now used.
Clinicians using a new viral screening test can not only diagnose Covid-19 in a matter of minutes with a portable, pocket-sized machine, but can also simultaneously test for other viruses.
A study finds patients are receptive to interacting with robots designed to evaluate symptoms in a contact-free way.
COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cellphone.
Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease.
Researchers are developing a COVID-19 testing method that uses a smartphone microscope to analyze saliva samples and deliver results in about 10 minutes.
How fast could SARS-CoV-2 be detected? Researchers have developed an accurate, high-speed, and portable detector for COVID-19.
Covid-19 gave many of these predictions for 2020 an entirely new spin: while some of the hyped trends turned out to play only bit-parts others became box-office hits in the new normal.
A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing.
Results of the first clinical trial of 3D printed NP swabs for COVID-19 testing are being presented at the annual meeting RSNA.
Scientists have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results.
Researchers have created a 3D printed self-adjusting smart swab that could be used for COVID-19 testing.
Researchers have developed a total of three swab designs that are comparable to the current ‘gold standard’ swabs.
Researchers have developed the world’s first fully automatic robot capable of carrying out throat swabs for COVID-19.
Scientists have developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes.
Establishing whether a patient is suffering from COVID-19 within a few minutes is possible using ultrasound machines that are enhanced with artificial intelligence.
Scientists have developed a novel test swab that can be 3D printed using inexpensive, widely available materials and speedily assembled in a range of fabrication settings.
In response to a request from the Commonwealth of Kentucky, faculty of University of Louisville have created a 3D printed swab made of a pliable resin material.
Scientists are creating from scratch a diagnostic lab with the capability to process more than 1,000 patient samples per day.
A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they've been in about a minute.
Scientists participating in the project “DrugTarget” have now developed a method that can quickly check the condition of the genome. This will help develop points of intervention for new medicines